Morten Herholdt
Stock Analyst at HSBC
(1.50)
# 3,241
Out of 4,835 analysts
17
Total ratings
41.67%
Success rate
-5.72%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $249.52 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $163.04 | +38.00% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $125.59 | +172.31% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $102.50 | -32.68% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $151.33 | +12.34% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $4.97 | +310.46% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $291.91 | +84.99% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $44.40 | +17.12% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $142.82 | +82.05% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $272.41 | +17.47% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.67 | +594.61% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $249.52
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $163.04
Upside: +38.00%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $125.59
Upside: +172.31%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $102.50
Upside: -32.68%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $151.33
Upside: +12.34%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $4.97
Upside: +310.46%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $291.91
Upside: +84.99%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $44.40
Upside: +17.12%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $142.82
Upside: +82.05%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $272.41
Upside: +17.47%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.67
Upside: +594.61%